LGALS3 and type 2 diabetes mellitus: The LV concentric hypertrophy was accompanied by an increased serum galectin-3 level in T2DM patients: 9.92 ng/mL [QIR: 8.38–12.96] vs. 8.14 ng/mL [QIR: 6.58–9.85], p = 0.039.